Study at a glance
Can active vitamin D be normal when the usual blood test shows a low level?
Yes. A normal 1,25-dihydroxyvitamin D result, which measures the active hormone, does not rule out low 25-hydroxyvitamin D, the main form measured in the usual vitamin D blood test.
Why can the active hormone stay normal?
The body controls active vitamin D to help maintain calcium balance. Parathyroid hormone, which helps control blood calcium, can encourage the kidneys to change more of the available 25-hydroxyvitamin D into active hormone.
Will active vitamin D always stay normal during deficiency?
No. When vitamin D supplies become very low, there may be too little starting material for the body to make up for the shortfall in this way. Kidney problems and other problems controlling mineral levels can also change the active-hormone result.
Which blood test usually checks vitamin D supply?
Total 25-hydroxyvitamin D is the usual blood test for checking vitamin D supply. Active vitamin D testing answers different, more specialised questions and does not show whether every tissue has adequate vitamin D activity.
Read the full article below ↓A normal active-vitamin-D result can look reassuring, especially when 1,25-dihydroxyvitamin D is described as the hormonally active form. But the body does not use circulating 1,25(OH)₂D as a passive reflection of its vitamin D stores. It regulates the active hormone aggressively. That is why a person can have low circulating 25(OH)D while 1,25(OH)₂D remains within the laboratory reference range.
The apparent contradiction comes from measuring two different layers of physiology
25(OH)D is the larger circulating substrate pool. It is formed mainly in the liver and is the biomarker normally used when vitamin D status needs to be assessed. 1,25(OH)₂D is produced mainly by the kidney and functions as an endocrine hormone. Its concentration is controlled according to mineral and hormonal signals, so it can be defended even when the substrate pool is declining.
This is the central distinction behind Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D. “Active” does not mean “best marker of how much vitamin D is available.” It means the metabolite sits at the hormone-output end of the pathway.
PTH can help preserve active hormone as 25(OH)D falls
When calcium availability is threatened, parathyroid hormone can stimulate renal CYP27B1, the enzyme that converts 25(OH)D into 1,25(OH)₂D. This is a homeostatic response: the body can increase the fraction of available substrate being activated in order to preserve calcium absorption and mineral balance. A falling 25(OH)D pool therefore does not have to produce an immediate fall in circulating active hormone.
A primary clinical study by Need and colleagues makes this visible. Among 319 patients with 25(OH)D at or below 40 nmol/L, active hormone and calcium absorption were maintained across much of the low-status range. The active-hormone result therefore looked comparatively preserved while the status marker was already low.
The compensation is real, but it is not unlimited
In the same dataset, the pattern changed in the most severely depleted group. When 25(OH)D was 10 nmol/L or lower, 1,25(OH)₂D and calcium absorption were lower and PTH was higher. At that point, substrate availability appeared too limited for homeostatic stimulation to maintain active-hormone production fully.
This prevents two opposite mistakes. It is wrong to say that low vitamin D status must produce low 1,25(OH)₂D immediately. It is also wrong to say that 1,25(OH)₂D will always stay normal or high in deficiency. The result depends on the severity of substrate depletion and on the renal and endocrine systems doing the regulating.
Kidney function and mineral hormones can shift the relationship further
Because the kidney is the major source of circulating 1,25(OH)₂D, impaired renal activation can lower the active hormone even if 25(OH)D is available. FGF23 can suppress renal activation, while PTH can stimulate it. Disorders involving calcium or phosphate balance can therefore change the relationship between the two blood tests. Vitamin D and Kidneys provides the wider renal context for that regulation.
A normal circulating active hormone also does not prove normal tissue signalling
Some tissues can convert 25(OH)D to 1,25(OH)₂D locally. This local production may act within or near the tissue without materially changing the amount of active hormone measured in blood. Conversely, a normal circulating active-hormone result does not show that every tissue is receiving or responding to the same signal.
This is why Vitamin D Status vs Vitamin D Effect matters. A blood concentration is a useful measurement, but biological effect depends on activation, degradation, receptor biology and tissue context as well.
“Active” describes biological role, not usefulness as a status marker
The terminology itself creates much of the confusion. 1,25(OH)₂D is called active because it is the high-affinity hormonal ligand that drives vitamin D receptor signalling. That does not mean its circulating concentration is the best way to estimate the amount of vitamin D available in the body. Hormones are often regulated precisely because their biological effects are powerful; their concentration can therefore be maintained by feedback even while the upstream substrate pool changes.
25(OH)D is less biologically active but more useful for the different task of status assessment. It is the major circulating metabolite, exists at much higher concentrations, and is more closely tied to the substrate supplied by skin synthesis, diet and supplementation. The two labels therefore describe different biological jobs rather than a ranking of which blood test is more informative in every setting.
What a normal 1,25(OH)₂D result can and cannot tell you
- It can describe the circulating concentration of the active endocrine metabolite at the time of sampling.
- It can be informative in selected disorders of renal activation, vitamin D resistance, inappropriate extra-renal production and phosphate regulation.
- It cannot by itself establish that the circulating 25(OH)D status pool is adequate.
- It cannot by itself rule out low vitamin D status.
- It cannot be assumed to remain normal in extreme substrate depletion or impaired renal activation.
- It does not measure the totality of local tissue activation or downstream vitamin D effect.
The useful mental model is substrate versus regulated output
The simplest way to avoid the confusion is to think of 25(OH)D as the main circulating substrate/status pool and 1,25(OH)₂D as a regulated hormonal output. The output can be defended for a time even while the pool shrinks, just as other endocrine systems can preserve a controlled variable by increasing regulatory effort. Eventually, however, severe substrate limitation or impaired organ function can constrain that compensation.
This model is more accurate than reading one result in isolation, and it explains why the “active” form is not automatically the most informative test of vitamin D status.
Primary evidence and source details
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency. Need AG et al. Journal of Bone and Mineral Research. 2008;23:1859 to 1863.
Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.
The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. Dirks NF et al. Nutrients. 2018;10:482.
Related reading
A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene
X-linked hypophosphatemia (XLH) is a rare inherited disorder of renal phosphate wasting with a highly variable phenotype caused by loss-of-function variants in the PHEX gene.
Original paper ↗Read more →Clinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossium
Histological examination shows that newly formed collagen is abnormal, lacking birefringence when examined by polarized light.
Original paper ↗Read more →Comprehensive Metabolomic Profiling in Adults with X-Linked Hypophosphatemia: A Case-Control Study
Conclusions: This study identified significant differences in the metabolic profiles of individuals with XLH compared to healthy controls.
Original paper ↗Read more →Disparities in Head and Neck Cancer: A Case for Chemoprevention with Vitamin D
Blacks experience disproportionate head and neck cancer (HNC) recurrence and mortality compared to Whites.
Original paper ↗Read more →Human milk-derived versus bovine milk-derived fortifier use in very low birth weight infants: growth and vitamin D status
Serum 25OHD level in the HMDF group was significantly higher compared with that in the BMDF group at 4 weeks of age despite receiving lower vitamin D supplementation.
Original paper ↗Read more →Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation
A single-center, double-blinded, randomized placebo-controlled clinical trial (NCT01304927) conducted in Copenhagen, Denmark.
Original paper ↗Read more →Perspectives of Differentiation Therapies of Acute Myeloid Leukemia: The Search for the Molecular Basis of Patients’ Variable Responses to 1,25-Dihydroxyvitamin D and Vitamin D Analogs
The concept of differentiation therapy of cancer is ~40 years old.
Original paper ↗Read more →Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center
This case study over time describes five years of experience with interventions to improve laboratory test utilization at an academic medical center.
Original paper ↗Read more →The vitamin D grey areas in pediatric primary care. Very low serum 25-hydroxyvitamin D levels in asymptomatic children living in northeastern Italy
The principal questions about the vitamin D topic are far to be resolved: in which children 25-hydroxyvitamin D blood testing is appropriate and how much cholecalciferol should be given in the absence of the test?
Original paper ↗Read more →Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets
Acute myeloid leukemia (AML) is an aggressive and often fatal hematopoietic malignancy.
Original paper ↗Read more →Vitamin D metabolites across the menstrual cycle: a systematic review
We aimed to assess if blood concentrations of 25-hydroxyvitamin D [25(OH)D] or 1,25-dihydroxyvitamin D [1,25(OH)2D] change across the menstrual cycle.
Original paper ↗Read more →25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Full Study
Explore why 25(OH)D reflects vitamin D status while 1,25(OH)₂D is a tightly regulated active hormone, including PTH, FGF23 and renal control.
Read more →25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Physiological Meaning and Regulation: Study Summary
A concise evidence summary explaining how 25(OH)D and 1,25(OH)₂D differ in physiological meaning, regulation and their roles in vitamin D testing.
Read more →Choosing the Correct Vitamin D Biomarker: Clinical Limitations and Misinterpretation Risks: Full Study
Review evidence on choosing the correct vitamin D biomarker, why 25(OH)D and 1,25(OH)₂D are confused, and how inappropriate testing can mislead.
Read more →Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D
A physiology-first explanation of vitamin D testing, comparing 25-OH-D and 1,25-OH₂-D and how each marker should be interpreted within regulated biological systems.
Read more →Choosing the Correct Vitamin D Biomarker: Clinical Limitations and Misinterpretation Risks: Study Summary
A concise evidence summary of vitamin D biomarker selection, common 25(OH)D and 1,25(OH)₂D testing errors, assay limitations and interpretation risks.
Read more →Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model
We investigated the influence of vitamin D analogs on the anticancer activity of 5-FU or capecitabine in the treatment of mice bearing MC38 mouse colon tumors implanted subcutaneously or orthotopically.
Original paper ↗Read more →Reading Vitamin D Signalling Experiments Across Time and Tissues
How exposure, timing, cell type and perturbation determine what a vitamin D signalling experiment can establish.
Read more →Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1)
Vitamin D enzyme pathways regulate how vitamin D is activated and broken down in the body.
Read more →Why Vitamin D Results Differ
Understand why vitamin D blood results vary with sunlight, diet, biology and laboratory methods, and why the context of each test matters.
Read more →Vitamin D Deficiency Definitions
Explains how vitamin D deficiency is defined, why thresholds vary, and how measurement, homeostasis, and functional context shape what deficiency actually means.
Read more →Original sources
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency
Published in Need AG et al. Journal of Bone and Mineral Research (2008).
Publication details
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency. Need AG et al. Journal of Bone and Mineral Research. 2008;23:1859 to 1863.
Vitamin D Assays
Published in Bikle DD. Frontiers of Hormone Research (2018).
Publication details
Vitamin D Assays. Bikle DD. Frontiers of Hormone Research. 2018;50:14 to 30.
The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine
We now have the ability to measure a number of different vitamin D metabolites with very accurate methods.
Publication details
The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine. Dirks NF et al. Nutrients. 2018;10:482.